In order to identify those cancer patients that have significant presence of individual TGF-β isoforms and have distinct pathway activation and consequently may more likely benefit from a TGF-Δ-isoform directed therapeutic intervention, we screened 1638 cancer samples from 13 different tumor types. Here, TGFB1 is linked to cancer.